Larger contralateral trigeminal nerve and hippocampus volumes are predictive of early nonresponse to surgical treatment of trigeminal neuralgia.
Higher systolic blood pressure and decreased low-density lipoprotein are associated with increased risk for peripheral neuropathy in patients with type 2 diabetes.
Although the prevalence of distal sensory peripheral neuropathy decreased following initiation of cART in people living with in resource-limiting settings, better strategies are needed.
Amphiphysin-IgG-mediated autoimmunity is an important clinical entity characterized by neuropathy.
When traditional oral analgesics no longer control pain, some physicians are turning to alternative drug delivery methods that provide pain relief while avoiding systemic adverse effects.
This study provides normative values for the bilateral lumbar and sacral-anorectal MEPs in healthy subject with no age or gender influence on rectal or anal MEP latency.
BoNT-A showed significant improvements in the frequency and severity of photophobia and eye discomfort.
There is limited evidence supporting the efficacy of cannabis for refractory chronic pain, including chronic neuropathic pain.
The FDA has granted Fast Track designation to ANX005 for the treatment of Guillain-Barré Syndrome, an autoimmune disease that can lead to widespread peripheral nerve damage and paralysis.
Investigators analyzed whether high LDL-C causally relates to risk for retinopathy, neuropathy, chronic kidney disease, and peripheral artery disease in the general population.